Enfusion Inc.

NYSE: ENFN · Real-Time Price · USD
10.76
-0.04 (-0.37%)
At close: Apr 17, 2025, 3:59 PM
10.76
0.00%
After-hours: Apr 17, 2025, 04:00 PM EDT

Enfusion Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Managed services Revenue 12.69M 11.77M 9.82M 7.12M
Managed services Revenue Growth +7.78% +19.88% +37.95% n/a
Other Revenue 1.4M 1.24M 1.66M 1.32M
Other Revenue Growth +12.71% -25.12% +25.57% n/a
Platform subscriptions Revenue 187.52M 161.52M 138.87M 103.26M
Platform subscriptions Revenue Growth +16.10% +16.31% +34.49% n/a

Revenue by Geography

Period Ending Dec 31, 2024
United States Revenue 122.4M
United States Revenue Growth n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 27.72M 25M 24.69M 26.44M 22.67M 22.22M 21.6M 18.56M 21.07M 20.37M 25.88M 30.73M 167.63M 13.45M 11.72M 9.54M 26.63M 6.58M 6.31M 6.31M
Selling, General, and Administrative Revenue Growth +10.86% +1.25% -6.60% +16.65% +1.99% +2.87% +16.40% -11.93% +3.45% -21.27% -15.78% -81.67% +1146.61% +14.73% +22.87% -64.17% +304.84% +4.30% 0.00% n/a
Research and Development Revenue 7.24M 6.84M 6.1M 6.55M 6.06M 4.94M 4.46M 4.43M 4.78M 3.86M 3.72M 4.8M 146.56M 2.6M 2.04M 2.2M 1.8M 1.64M 1.44M 1.44M
Research and Development Revenue Growth +5.79% +12.24% -6.95% +8.08% +22.77% +10.60% +0.74% -7.20% +23.58% +3.82% -22.49% -96.72% +5536.77% +27.39% -7.31% +22.54% +9.44% +14.07% 0.00% n/a
Sales and Marketing Revenue 6.57M 6.22M 6.02M 6.22M 5.55M 5.5M 5.28M 4.09M 6M 7.28M 7.58M 8.43M 39.4M 4.9M 4.26M 3.16M 3.31M 2.07M 2.27M 2.27M
Sales and Marketing Revenue Growth +5.61% +3.32% -3.15% +11.98% +0.89% +4.28% +29.15% -31.91% -17.55% -3.92% -10.16% -78.60% +703.96% +14.94% +35.02% -4.65% +60.15% -9.04% 0.00% n/a